United States Organ-On-Chip (OOC) Market Outlook 2024

Report Overview:

 This report presents an overview of United States market for Organ-OnChip (OOC) , sales, revenue and price. Analyses of the United States market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

 This report focuses on the Organ-On-Chip (OOC) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the United States OrganOn-Chip (OOC) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues.

 This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

Market Value:

 United States Organ-On-Chip (OOC) market was valued at US$ 87.5 million in 2024 and is projected to reach US$ 256.8 million by 2030, at a CAGR of 19.6% during the forecast period 2024-2030.

By Types:

• Brain-on-a-chip

• Liver-on-a-chip

• Kidney-on-a-chip

• Lung-on-a-chip

• Heart-on-a-chip

• Intestine-on-a-chip

• Other

By Applications: Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Cosmetics Industry Other

Key players include:

• Emulate, Inc.

Organovo Holdings Inc.

Hesperos, Inc.

Nortis, Inc.

Tara Biosystems, Inc.

TissUse GmbH

AxoSim, Inc.

CN Bio Innovations

MIMETAS

• Draper

• Including or excluding key companies relevant to your analysis.